Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ophthotech Corp (NASDAQ:OPHT)

47.88
Delayed Data
As of Apr 28
 -0.44 / -0.91%
Today’s Change
35.72
Today|||52-Week Range
80.00
-39.03%
Year-to-Date

Today’s Trading

Previous close48.32
Today’s open48.03
Day’s range47.23 - 49.71
Volume376,081
Average volume (3 months)601,728
Market cap$1.7B
Dividend yield--
Data as of 04/28/2016

Growth & Valuation

Earnings growth (last year)-3.73%
Earnings growth (this year)-74.85%
Earnings growth (next 5 years)--
Revenue growth (last year)+24.83%
P/E ratioNM
Price/Sales52.72
Price/Book28.37

Competitors

 Today’s
change
Today’s
% change
BLUEbluebird bio Inc-1.22-2.63%
RDUSRadius Health Inc-0.85-2.27%
NVAXNovavax Inc-0.02-0.37%
HALOHalozyme Therapeutic...-0.11-1.00%
Data as of 04/28/2016

Financials

Next reporting dateMay 4, 2016
EPS forecast (this quarter)-$1.26
Annual revenue (last year)$51.5M
Annual profit (last year)-$105.7M
Net profit margin-205.26%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
David R. Guyer
President &
Vice Chairman
Samir Chandrakant Patel
Corporate headquarters
New York, New York

Forecasts

Partner Offers

Search for Jobs